Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dopaminergic D2-like agonists produce yawning in the myelin mutant taiep and Sprague-Dawley rats.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Coenzyme Q10 supplementation and multiple sclerosis.
Vagomimetic effects of fingolimod: physiology and clinical implications.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Impairment of visuospatial/visuoconstructional skills in multiple sclerosis patients: the correlation with regional lesion load and subcortical atrophy.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Genetically Modified Pig Models for Neurodegenerative Disorders.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases.
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.
Immunopathology of multiple sclerosis.
Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis.
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men.
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.
Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis: Results From a United States Network.
Grey matter damage in multiple sclerosis: A pathology perspective.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.

Pages